GENEVA, 15 December – Unitaid has adopted a new five-year strategy that will enable it to support global efforts to end HIV/AIDS, malaria and tuberculosis over the next two decades and help reduce inequities in access to healthcare.
This article originally appears as a news release on the University of Liverpool website
Geneva, 1 December – UNITAID welcomes new WHO guidelines that recommend the use of HIV self-testing to help get millions of people who do not know they are infected with HIV diagnosed and put on treatment. The guidelines are borne out by preliminary results from the world’s largest evaluation of HIV self-testing, funded by UNITAID in Malawi, Zambia and Zimbabwe. The results show that HIV self-tests can reach those who have never tested before for HIV and that self-tests are popular among people who are less likely to test such as young people and men.
UNITAID - CHAI grant aims to drive savings of $1.6 billion through 2024
London, 30 November 2016 – UNITAID and the Clinton Health Access Initiative (CHAI) today announced a three-year project to speed the introduction of new, optimal HIV drugs, and make them more available and affordable. The US $ 34 million investment is expected to be a boon for adults and children living with HIV who receive treatments that are not effective. In addition, 18 million people who do not receive any treatment stand to benefit from this project.
YAOUNDE, November 16 - A study launched in Yaoundé will test the latest generation of HIV treatment based on Dolutegravir under local conditions, with a view to establishing its viability in Africa. The treatment is already widely available in developed countries.
